Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Pediatric Surgery|June 2, 1998
Splenectomy in a child with chronic Mycobacterium avium complex infection and splenic sequestrationH L Kaufman, M Roden, D Nathanson, et al.Cancer Research|December 4, 2001
A new mouse model for evaluating the immunotherapy of human colorectal cancerH Hörig, A Wainstein, L Long, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 26, 1999
Interleukin-10 enhances the therapeutic effectiveness of a recombinant poxvirus-based vaccine in an experimental murine tumor modelH L Kaufman, J B Rao, K R Irvine, et al.The Journal of Biological Chemistry|July 14, 2001
Palmitoylation of caveolin-1 at a single site (Cys-156) controls its coupling to the c-Src tyrosine kinase: targeting of dually acylated molecules (GPI-linked, transmembrane, or cytoplasmic) to caveolae effectively uncouples c-Src and caveolin-1 (TYR-14)H Lee, S E Woodman, J A Engelman, et al.Proceedings of the National Academy of Sciences of the United States of America|April 5, 2001
Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytesG A Kicska, L Long, H Hörig, et al.Cancer Immunology, Immunotherapy : CII|November 25, 2000
Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory moleculeH Hörig, D S Lee, W Conkright, et al.Infection Control and Hospital Epidemiology|November 18, 2000
Clinical infection control in gene therapy: a multidisciplinary conferenceM E Evans, C T Jordan, S M Chang, et al.Journal for Immunotherapy of Cancer|November 23, 2017
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working GroupI Puzanov, A Diab, K Abdallah, et al.Pageof 2